PCA(P)(2022)25 - Extension on 12 Serious Shortage Protocols (SSPs) Issued Recently for Hormone Replacement Therapies

Published: 29/07/22

Woman holding Hormone Replacement Therapy Medicine.

Summary

This Circular advises NHS Boards and community pharmacy contractors of an extension on 12 Serious Shortage Protocols (SSPs) issued recently for Hormone Replacement Therapies.

Detail

Extensions have been applied to SSPs for the following HRT products: Oestrogel®; Ovenstin®; Lenzetto® spray; and Sandrena® gel. Each SSP has been extended until 29 October 2022. Please refer to Annex A for a detailed list of all 12 SSPs which have been extended.

The SSP for Premique® tablets will be allowed to expire on its existing end date of 29 July 2022 as supplies have stabilised.

Scottish Government

The devolved government for Scotland has a range of responsibilities that include: the economy, education, health, justice, rural affairs, housing, etc...

https://www.gov.scot/
Previous
Previous

PCA(P)(2022)26 - NHS Pharmacy First Scotland - Updated PGDs

Next
Next

PCA(P)(2022)24 - Community Pharmacy Public Health Service Poster Campaigns 2022